Plenty of talk in that interview about Professor Gil Mor at Yale this guy had collected a whole library of cancer stem cells from ovarian cancers which Novogen's drug Trx - 1 wiped out - he's a believer:
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint